228 related articles for article (PubMed ID: 15818055)
1. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
Cavarzere P; Camilot M; Teofoli F; Tatò L
Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055
[TBL] [Abstract][Full Text] [Related]
2. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
Fingerhut R
Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
[TBL] [Abstract][Full Text] [Related]
3. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
[TBL] [Abstract][Full Text] [Related]
4. [Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
Zhang Q; Wang B; Chen Y; Jiang D; Chen Y
Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):706-9. PubMed ID: 25476436
[TBL] [Abstract][Full Text] [Related]
5. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
Lee JE; Moon Y; Lee MH; Jun YH; Oh KI; Choi JW
Ann Clin Lab Sci; 2008; 38(3):235-40. PubMed ID: 18715851
[TBL] [Abstract][Full Text] [Related]
6. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
Balsamo A; Cacciari E; Piazzi S; Cassio A; Bozza D; Pirazzoli P; Zappulla F
Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
[TBL] [Abstract][Full Text] [Related]
7. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
Gu X; Zhou J; Ye J
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
[TBL] [Abstract][Full Text] [Related]
8. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
[TBL] [Abstract][Full Text] [Related]
9. Multiple positive results during a neonatal screening program: a retrospective analysis of incidence, clinical implications and outcomes.
Zaffanello M; Maffeis C; Zamboni G
J Perinat Med; 2005; 33(3):246-51. PubMed ID: 15914349
[TBL] [Abstract][Full Text] [Related]
10. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value.
Olgemöller B; Roscher AA; Liebl B; Fingerhut R
J Clin Endocrinol Metab; 2003 Dec; 88(12):5790-4. PubMed ID: 14671170
[TBL] [Abstract][Full Text] [Related]
11. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
12. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.
Jiang X; Tang F; Feng Y; Li B; Jia X; Tang C; Liu S; Huang Y
J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1253-1258. PubMed ID: 31603856
[TBL] [Abstract][Full Text] [Related]
13. Neonatal screening program for congenital adrenal hyperplasia: adjustments to the recall protocol.
Gruñeiro-Papendieck L; Prieto L; Chiesa A; Bengolea S; Bossi G; Bergadá C
Horm Res; 2001; 55(6):271-7. PubMed ID: 11805430
[TBL] [Abstract][Full Text] [Related]
14. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
[TBL] [Abstract][Full Text] [Related]
15. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
al Saedi S; Dean H; Dent W; Stockl E; Cronin C
Pediatrics; 1996 Jan; 97(1):100-2. PubMed ID: 8545200
[TBL] [Abstract][Full Text] [Related]
16. High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland.
Steigert M; Schoenle EJ; Biason-Lauber A; Torresani T
J Clin Endocrinol Metab; 2002 Sep; 87(9):4106-10. PubMed ID: 12213856
[TBL] [Abstract][Full Text] [Related]
17. [Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
Cattani A; Reyes ML; Azócar M; Soto J; Romeo E; Valdivia L; Poggi H; Foradori A
Rev Med Chil; 2000 Oct; 128(10):1113-8. PubMed ID: 11349510
[TBL] [Abstract][Full Text] [Related]
18. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
Varness TS; Allen DB; Hoffman GL
J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
[TBL] [Abstract][Full Text] [Related]
20. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
Gatelais F; Berthelot J; Beringue F; Descamps P; Bonneau D; Limal JM; Coutant R
Pediatr Res; 2004 Nov; 56(5):701-5. PubMed ID: 15371568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
